CELLTRION HEALTHCARE SINGAPORE PRIVATE LIMITED

🇸🇬Singapore

Country: 🇸🇬Singapore

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

0

Active:0

Completed:0

Trial Phases

0 Phases

Drug Approvals

13

HSA:13

Drug Approvals

VEGZELMA CONCENTRATE FOR SOLUTION FOR INFUSION 25 MG/ML

Approval Date: Jun 16, 2023

HSA

YUFLYMA SOLUTION FOR INJECTION IN PRE-FILLED PEN 40MG/0.4ML

Approval Date: Jun 9, 2022

HSA

REMSIMA SOLUTION FOR SUBCUTANEOUS INJECTION 120 MG/ML IN PRE-FILLED PEN

Approval Date: Dec 29, 2020

HSA

REMSIMA SOLUTION FOR SUBCUTANEOUS INJECTION 120 MG/ML IN PRE-FILLED SYRINGE

Approval Date: Dec 29, 2020

HSA

HERZUMA® 440MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION

Approval Date: Oct 29, 2019

HSA

HERZUMA® 150MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION

Approval Date: Oct 29, 2019

HSA

TRUXIMA® CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML

Approval Date: Apr 24, 2019

HSA

REMSIMA® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/VIAL

Approval Date: Mar 28, 2016

HSA

DORIBAX™ Powder for Injection 500mg

Approval Date: Mar 13, 2009

HSA

ACTOS TABLET 15 mg

Approval Date: Oct 10, 2003

HSA

Prev
1
2
Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

Privacy Policy
Terms & Conditions

© 2025 MedPath, Inc. All rights reserved.